European implementation of Medical Device and IVD Regulations – Implications for Australia
TGA – European implementation of Medical Device and IVD Regulations – Implications for Australia
Published in In Vitro Diagnostic Medical Device Regulation IVDR, Medical Device Regulation MDR and Therapeutic Goods Administration - TGA
More from In Vitro Diagnostic Medical Device Regulation IVDRMore posts in In Vitro Diagnostic Medical Device Regulation IVDR »
- EU – Team NB position statement on the requirements for the EU MDR/IVDR Notified Body Partners under the Technical Cooperation Program on Exchange of Medical Device Quality Management System Regulation and ISO 13485 Audit Reports (TCP III)
- EU – Mandate M/565 COMMISSION IMPLEMENTING DECISION C(2020) 2532 of 15.5.2020 on a standardisation request to the CEN and the CENELEC in support of Regulation (EU) 2017/745 and Regulation (EU) 2017/746
- EU – Manufacturer incident report 2020
- EU – Ongoing Guidance development within MDCG Subgroups
- EU – Privacy statement – Call for expression of interest for expert panels on medical devices and in vitro diagnostic medical devices (2019/C 323/05)
More from Medical Device Regulation MDRMore posts in Medical Device Regulation MDR »
- EU – Guidance – Clinical evaluation assessment report template
- EU – Team NB position statement on the requirements for the EU MDR/IVDR Notified Body Partners under the Technical Cooperation Program on Exchange of Medical Device Quality Management System Regulation and ISO 13485 Audit Reports (TCP III)
- UK – MHRA – Medical Device “Certificates of Compliance” / “Attestation of Conformity” have no legal standing under MDR
- EU – COMMUNICATION FROM THE COMMISSION Guidelines on the adoption of Union-wide derogations for medical devices in accordance with Article 59 of Regulation (EU) 2017/745
- EU – Mandate M/565 COMMISSION IMPLEMENTING DECISION C(2020) 2532 of 15.5.2020 on a standardisation request to the CEN and the CENELEC in support of Regulation (EU) 2017/745 and Regulation (EU) 2017/746
More from Therapeutic Goods Administration - TGAMore posts in Therapeutic Goods Administration - TGA »
- Australia – TGA – 3-D printing (additive manufacturing) of medical devices
- Australia – TGA – Actual and potential harm caused by medical software
- TGA – Regulation impact statement: Proposed regulatory scheme for personalised medical devices, including 3D-printed devices
- TGA – Medical device application processing times
- TGA guidance – Researcher considerations for medical devices Meeting the evidence requirements for market authorisation
Be First to Comment